The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Lipertance 20mg/10mg/5mg film-coated tablets

Les Laboratoires ServierPA0568/028/003

Main Information

Trade NameLipertance 20mg/10mg/5mg film-coated tablets
Active SubstancesAtorvastatin
Perindopril arginine
Dosage FormFilm-coated tablet
Licence HolderLes Laboratoires Servier
Licence NumberPA0568/028/003

Group Information

ATC CodeC10BX HMG CoA reductase inhibitors, other combinations
C10BX11 ZZZ atorvastatin, amlodipine and perindopril


License statusAuthorised
Licence Issued23/10/2015
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back